Oramed Pharmaceuticals
ORMP
ORMP
77 hedge funds and large institutions have $43.2M invested in Oramed Pharmaceuticals in 2022 Q4 according to their latest regulatory filings, with 20 funds opening new positions, 17 increasing their positions, 17 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding
Funds holding: →
0% more repeat investments, than reductions
Existing positions increased: 17 | Existing positions reduced: 17
0.94% less ownership
Funds ownership: 10.15% → 9.21% (-0.94%)
Holders
77
Holding in Top 10
–
Calls
$5.34M
Puts
$3.72M
Top Buyers
| 1 | +$4.61M | |
| 2 | +$1.44M | |
| 3 | +$1.09M | |
| 4 |
Group One Trading
Chicago,
Illinois
|
+$757K |
| 5 |
XT
XTX Topco
George Town,
Cayman Islands
|
+$687K |
Top Sellers
| 1 | -$2.53M | |
| 2 | -$1.12M | |
| 3 | -$1.06M | |
| 4 |
Two Sigma Advisers
New York
|
-$958K |
| 5 |
EMG
ETF Managers Group
Summit,
New Jersey
|
-$612K |